Viewing Study NCT07265232


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT07265232
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-11-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).
Sponsor: Lantu Biopharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module